- 专利标题： Therapy for transthyretin-associated amyloidosis
-
申请号： US17005893申请日： 2020-08-28
-
公开(公告)号： US11564899B2公开(公告)日： 2023-01-31
- 发明人: Marc Centellas Casado , Raúl Insa Boronat , Nuria Reig Bolaño , Núria Gavaldà Batalla
- 申请人： SOM INNOVATION BIOTECH, S.L.
- 申请人地址： ES Barcelona
- 专利权人： SOM INNOVATION BIOTECH, S.L.
- 当前专利权人： SOM INNOVATION BIOTECH, S.L.
- 当前专利权人地址： ES Barcelona
- 代理机构： King & Spalding
- 优先权： EP11382326 20111024
- 主分类号： A61K31/165
- IPC分类号： A61K31/165 ; A61K9/16 ; A61K31/198 ; A61K45/06 ; A61K31/12 ; A61K31/353 ; A61K31/603 ; A61K31/423 ; A61K31/192
摘要：
It is provided a catechol-O-methyltransferase (COMT) inhibitor for use in the prevention and/or treatment of transthyretin-associated amyloidosis. It is also provided a catechol-O-methyltransferase (COMT) inhibitor for use in the prevention and/or treatment of transthyretin-associated amyloidosis in combination therapy with another COMT inhibitor, a benzoxazole derivative, iododiflunisal, diflunisal, resveratrol, tauroursodeoxycholic acid, doxocycline, or epigallocatechin-3-gallate.
信息查询
